Patria Alba Aponte
Pediatric Endocrinology · Topeka, KSNPI 1689942518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,279, 3.9 times the $326 reported in 2019.
Across 191 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$727
- AbbVie$650
- Ascendis Pharma Endocrinology Inc$306
- Neurocrine Biosciences, Inc.$233
- Eton Pharmaceuticals, Inc.$223
- Kyowa Kirin, Inc.$209
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,01797%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $727 |
| AbbVie | 45 | $650 |
| Ascendis Pharma Endocrinology Inc | 15 | $306 |
| Neurocrine Biosciences, Inc. | 9 | $233 |
| Eton Pharmaceuticals, Inc. | 1 | $223 |
| Kyowa Kirin, Inc. | 6 | $209 |
| Medtronic(2 entities) | 5 | $209 |
| Insulet Corporation | 5 | $204 |
| Abbott | 8 | $186 |
| Sanofi-aventis U.S. LLC | 7 | $125 |
| BETA Bionics, Inc. | 8 | $121 |
| AstraZeneca | 5 | $119 |
| Tolmar, Inc. | 5 | $105 |
| Pfizer | 6 | $97 |
| Biomarin Pharmaceutical Inc. | 3 | $83 |
| Xeris Pharmaceuticals, Inc. | 3 | $78 |
| Dexcom, Inc. | 4 | $72 |
| Tandem Diabetes Care, Inc. | 4 | $63 |
| Lilly USA, LLC | 3 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Tolmar Pharmaceuticals, Inc. | 2 | $37 |
| Endo USA, Inc. | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Sequel Med Tech, LLC | 1 | $27 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Corcept Therapeutics | 2 | $23 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alkindi$223
- KHINDIVI$223
- INCRELEX$223
- CRYSVITA$126
- Omnipod$125
- CRENESSITY$125
- MINIMED 780G$111
How this compares
Too few pediatric endocrinology providers in Kansasto place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Topeka
- Katie BargerTopeka$2K
- Jacob RedelTopeka$2K
- James CaseyTopeka$1K
- Tiffany MusickTopeka$228
- Larry MidyettOverland Park$210K
- Shilpi RelanWichita$2K
- Fadi Al MuhaisenWichita$612
- Christopher BlueWichita$465
- Katarina GambosovaLawrence$435
- Lina SaadehWichita$303
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.